US Stock MarketDetailed Quotes

Vanda Pharmaceuticals (VNDA)

Watchlist
  • 7.270
  • +0.110+1.54%
Close Apr 17 16:00 ET
  • 7.168
  • -0.102-1.41%
Post 18:58 ET
429.72MMarket Cap-1.94P/E (TTM)

Vanda Pharmaceuticals (VNDA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-594.56%-109.44M
-1,518.99%-29.42M
-116.90%-31.63M
-120.15%-15.25M
-537.93%-33.15M
-223.09%-15.76M
51.31%-1.82M
-611.27%-14.58M
47.59%-6.93M
-76.20%7.57M
Net income from continuing operations
-1,066.53%-220.47M
-2,774.33%-141.19M
-324.23%-22.59M
-502.19%-27.21M
-611.38%-29.49M
-853.29%-18.9M
-104.67%-4.91M
-3,986.13%-5.32M
-397.24%-4.52M
-227.49%-4.15M
Depreciation and amortization
21.61%11.92M
61.07%5.86M
4.37%2.05M
2.54%2.02M
-10.84%1.98M
126.10%9.8M
46.66%3.64M
239.14%1.97M
226.91%1.97M
231.94%2.22M
Deferred tax
1,356.45%81.44M
5,491.12%103.19M
-93.46%-5.97M
-546.03%-7.97M
-3,069.51%-7.8M
-404.04%-6.48M
74.43%-1.91M
-213.16%-3.09M
-184.81%-1.23M
-112.21%-246K
Other non cash items
105.39%1.94M
-234.86%-2.33M
187.78%1.39M
99.23%1.03M
189.08%1.85M
-54.84%946K
-2.95%-697K
-47.95%483K
-29.39%519K
-42.20%641K
Change In working capital
226.68%8.31M
321.45%3.03M
15.71%-8.13M
432.15%15.32M
-127.43%-1.91M
-777.91%-6.56M
-74.54%718K
-42.22%-9.64M
75.50%-4.61M
-68.34%6.98M
-Change in receivables
42.65%-7.46M
8.03%-4.08M
-570.96%-5.57M
93.16%-353K
197.95%2.53M
-1,740.45%-13.01M
8.37%-4.43M
-119.18%-830K
43.25%-5.16M
-129.06%-2.59M
-Change in inventory
-11,851.72%-3.47M
-1,096.26%-1.28M
114.95%32K
-239.92%-368K
-6,479.31%-1.85M
96.24%-29K
74.94%-107K
61.37%-214K
93.38%263K
-60.81%29K
-Change in prepaid assets
-77.04%-12.07M
-63.43%-5.94M
119.20%703K
-10.63%-1.44M
-402.64%-5.39M
-179.97%-6.82M
-150.58%-3.64M
49.10%-3.66M
53.94%-1.3M
-84.30%1.78M
-Change in payables and accrued expense
826.23%15.82M
526.75%9.08M
-2,079.74%-10.22M
260.94%11.33M
383.78%5.64M
115.55%1.71M
-163.85%-2.13M
-67.50%-469K
196.76%3.14M
110.80%1.17M
-Change in other working capital
33.59%15.48M
-52.38%5.25M
255.19%6.93M
495.94%6.15M
-143.16%-2.84M
263.13%11.59M
552.01%11.02M
-45.05%-4.47M
59.15%-1.55M
-47.33%6.59M
Cash from discontinued investing activities
Operating cash flow
-594.56%-109.44M
-1,518.99%-29.42M
-116.90%-31.63M
-120.15%-15.25M
-537.93%-33.15M
-223.09%-15.76M
51.31%-1.82M
-611.27%-14.58M
47.59%-6.93M
-76.20%7.57M
Investing cash flow
Cash flow from continuing investing activities
644.23%94.86M
1,023.62%44.87M
77.18%21.36M
-0.05%-15.27M
340.98%43.9M
-44.58%-17.43M
109.12%3.99M
-65.87%12.06M
92.00%-15.26M
-109.73%-18.22M
Net PPE purchase and sale
-103.67%-998K
52.34%-102K
0.00%-161K
-176.85%-299K
-6,128.57%-436K
-27.94%-490K
15.42%-214K
-570.83%-161K
-96.36%-108K
86.27%-7K
Net investment purchase and sale
854.13%95.86M
968.89%44.97M
76.16%21.52M
-9.84%-14.97M
385.94%44.34M
-114.28%-12.71M
-92.64%4.21M
-65.44%12.22M
92.86%-13.63M
-108.28%-15.51M
Net other investing changes
----
----
----
----
----
95.80%-4.23M
--0
--0
---1.52M
---2.71M
Cash from discontinued investing activities
Investing cash flow
644.23%94.86M
1,023.62%44.87M
77.18%21.36M
-0.05%-15.27M
340.98%43.9M
-44.58%-17.43M
109.12%3.99M
-65.87%12.06M
92.00%-15.26M
-109.73%-18.22M
Financing cash flow
Cash flow from continuing financing activities
-1,774.84%-2.91M
-312.90%-640K
-517K
-425K
-1.32M
-155K
-155K
0
0
0
Net issuance payments of debt
-1,184.52%-1.99M
-312.90%-640K
---517K
---425K
---409K
---155K
---155K
--0
--0
--0
Proceeds from stock option exercised by employees
----
----
----
----
----
--0
----
----
----
----
Net other financing activities
---915K
--0
--0
--0
---915K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-1,774.84%-2.91M
-312.90%-640K
---517K
---425K
---1.32M
---155K
---155K
--0
--0
--0
Net cash flow
Beginning cash position
-24.58%102.79M
-30.18%70.49M
-21.24%81.45M
-10.64%112.27M
-24.58%102.79M
0.58%136.29M
-45.02%100.97M
-31.28%103.42M
-64.58%125.63M
0.58%136.29M
Current changes in cash
47.55%-17.49M
632.76%14.81M
-327.14%-10.78M
-39.46%-30.95M
188.56%9.43M
-4,575.44%-33.34M
104.25%2.02M
-107.58%-2.52M
89.13%-22.19M
-104.86%-10.65M
Effect of exchange rate changes
114.11%23K
109.90%20K
-364.71%-180K
993.33%134K
450.00%49K
-446.81%-163K
-234.67%-202K
155.74%68K
42.31%-15K
-131.11%-14K
End cash Position
-16.99%85.32M
-16.99%85.32M
-30.18%70.49M
-21.24%81.45M
-10.64%112.27M
-24.58%102.79M
-24.58%102.79M
-45.02%100.97M
-31.28%103.42M
-64.58%125.63M
Free cash flow
-579.76%-110.44M
-1,353.42%-29.52M
-115.62%-31.79M
-121.02%-15.55M
-544.10%-33.58M
-230.83%-16.25M
49.03%-2.03M
-610.80%-14.74M
47.00%-7.04M
-76.18%7.56M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -594.56%-109.44M-1,518.99%-29.42M-116.90%-31.63M-120.15%-15.25M-537.93%-33.15M-223.09%-15.76M51.31%-1.82M-611.27%-14.58M47.59%-6.93M-76.20%7.57M
Net income from continuing operations -1,066.53%-220.47M-2,774.33%-141.19M-324.23%-22.59M-502.19%-27.21M-611.38%-29.49M-853.29%-18.9M-104.67%-4.91M-3,986.13%-5.32M-397.24%-4.52M-227.49%-4.15M
Depreciation and amortization 21.61%11.92M61.07%5.86M4.37%2.05M2.54%2.02M-10.84%1.98M126.10%9.8M46.66%3.64M239.14%1.97M226.91%1.97M231.94%2.22M
Deferred tax 1,356.45%81.44M5,491.12%103.19M-93.46%-5.97M-546.03%-7.97M-3,069.51%-7.8M-404.04%-6.48M74.43%-1.91M-213.16%-3.09M-184.81%-1.23M-112.21%-246K
Other non cash items 105.39%1.94M-234.86%-2.33M187.78%1.39M99.23%1.03M189.08%1.85M-54.84%946K-2.95%-697K-47.95%483K-29.39%519K-42.20%641K
Change In working capital 226.68%8.31M321.45%3.03M15.71%-8.13M432.15%15.32M-127.43%-1.91M-777.91%-6.56M-74.54%718K-42.22%-9.64M75.50%-4.61M-68.34%6.98M
-Change in receivables 42.65%-7.46M8.03%-4.08M-570.96%-5.57M93.16%-353K197.95%2.53M-1,740.45%-13.01M8.37%-4.43M-119.18%-830K43.25%-5.16M-129.06%-2.59M
-Change in inventory -11,851.72%-3.47M-1,096.26%-1.28M114.95%32K-239.92%-368K-6,479.31%-1.85M96.24%-29K74.94%-107K61.37%-214K93.38%263K-60.81%29K
-Change in prepaid assets -77.04%-12.07M-63.43%-5.94M119.20%703K-10.63%-1.44M-402.64%-5.39M-179.97%-6.82M-150.58%-3.64M49.10%-3.66M53.94%-1.3M-84.30%1.78M
-Change in payables and accrued expense 826.23%15.82M526.75%9.08M-2,079.74%-10.22M260.94%11.33M383.78%5.64M115.55%1.71M-163.85%-2.13M-67.50%-469K196.76%3.14M110.80%1.17M
-Change in other working capital 33.59%15.48M-52.38%5.25M255.19%6.93M495.94%6.15M-143.16%-2.84M263.13%11.59M552.01%11.02M-45.05%-4.47M59.15%-1.55M-47.33%6.59M
Cash from discontinued investing activities
Operating cash flow -594.56%-109.44M-1,518.99%-29.42M-116.90%-31.63M-120.15%-15.25M-537.93%-33.15M-223.09%-15.76M51.31%-1.82M-611.27%-14.58M47.59%-6.93M-76.20%7.57M
Investing cash flow
Cash flow from continuing investing activities 644.23%94.86M1,023.62%44.87M77.18%21.36M-0.05%-15.27M340.98%43.9M-44.58%-17.43M109.12%3.99M-65.87%12.06M92.00%-15.26M-109.73%-18.22M
Net PPE purchase and sale -103.67%-998K52.34%-102K0.00%-161K-176.85%-299K-6,128.57%-436K-27.94%-490K15.42%-214K-570.83%-161K-96.36%-108K86.27%-7K
Net investment purchase and sale 854.13%95.86M968.89%44.97M76.16%21.52M-9.84%-14.97M385.94%44.34M-114.28%-12.71M-92.64%4.21M-65.44%12.22M92.86%-13.63M-108.28%-15.51M
Net other investing changes --------------------95.80%-4.23M--0--0---1.52M---2.71M
Cash from discontinued investing activities
Investing cash flow 644.23%94.86M1,023.62%44.87M77.18%21.36M-0.05%-15.27M340.98%43.9M-44.58%-17.43M109.12%3.99M-65.87%12.06M92.00%-15.26M-109.73%-18.22M
Financing cash flow
Cash flow from continuing financing activities -1,774.84%-2.91M-312.90%-640K-517K-425K-1.32M-155K-155K000
Net issuance payments of debt -1,184.52%-1.99M-312.90%-640K---517K---425K---409K---155K---155K--0--0--0
Proceeds from stock option exercised by employees ----------------------0----------------
Net other financing activities ---915K--0--0--0---915K--------------------
Cash from discontinued financing activities
Financing cash flow -1,774.84%-2.91M-312.90%-640K---517K---425K---1.32M---155K---155K--0--0--0
Net cash flow
Beginning cash position -24.58%102.79M-30.18%70.49M-21.24%81.45M-10.64%112.27M-24.58%102.79M0.58%136.29M-45.02%100.97M-31.28%103.42M-64.58%125.63M0.58%136.29M
Current changes in cash 47.55%-17.49M632.76%14.81M-327.14%-10.78M-39.46%-30.95M188.56%9.43M-4,575.44%-33.34M104.25%2.02M-107.58%-2.52M89.13%-22.19M-104.86%-10.65M
Effect of exchange rate changes 114.11%23K109.90%20K-364.71%-180K993.33%134K450.00%49K-446.81%-163K-234.67%-202K155.74%68K42.31%-15K-131.11%-14K
End cash Position -16.99%85.32M-16.99%85.32M-30.18%70.49M-21.24%81.45M-10.64%112.27M-24.58%102.79M-24.58%102.79M-45.02%100.97M-31.28%103.42M-64.58%125.63M
Free cash flow -579.76%-110.44M-1,353.42%-29.52M-115.62%-31.79M-121.02%-15.55M-544.10%-33.58M-230.83%-16.25M49.03%-2.03M-610.80%-14.74M47.00%-7.04M-76.18%7.56M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More